Benjamin Li
Mar 5, 2010

Mindshare, Aegis Media, OMD and ZenithOptimedia vie for Xian-Janssen Pharmaceutical media planning account in China

BEIJING - Johnson & Johnson owned Xian-Janssen Pharmaceutical Company has called a media planning review in China.

Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Mindshare, Aegis Media, OMD and ZenithOptimedia are understood to be involved in the pitch.

According to agency sources, the account is a “good size and meaningful” and is worth an estimated US$15 million.

OMD holds the media buying account for Johnson & Johnson. The agency won the business in 2007, which also includes Shanghai Johnson & Johnson Pharmaceuticals and Johnson & Johnson Vision Care.

Motilium and Daktarin are among Xian-Janssen Pharmaceutical's main products in China.


 
Source:
Campaign China

Related Articles

Just Published

16 hours ago

'Looking for the first domino': Titanium jury ...

In a wide-ranging interview, John explains how APAC work, like New Zealand’s stigma-smashing Grand Prix for Good and Ogilvy Singapore’s work for Vaseline, are setting the stage for global creative change.

23 hours ago

John Wren on his vision for a bigger, better Omnicom

The chief executive tells Campaign why the IPG acquisition makes sense, what the impact will be and what will determine success.

1 day ago

Big ideas, not big algorithms, will win Cannes

At Cannes 2025, Adobe’s Shantanu Narayen and Publicis’ Arthur Sadoun unpacked why AI may power creativity—but humans still pilot it.

1 day ago

Campaign Cannes Global Podcast Episode 2

Our editors from the UK, US, Canada and APAC report from Campaign House at Cannes Lions 2025.